Get the Stockscreener App
4.37
0.23%
0.010
After Hours:
4.34
-0.03
-0.69%
Organogenesis Holdings Inc Stock (ORGO) Forecast
The Organogenesis Holdings Inc (ORGO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.155, representing a -96.45% decrease from the current price of $4.37. The highest analyst price target is $0.2065, and the lowest is $0.1035.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ORGO Price Target
Average 10.48
(+139.78% Upside)
Is Organogenesis Holdings Inc (ORGO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 59.61 | Neutral |
| STOCH(9,6) | 63.06 | Neutral |
| STOCHRSI(14) | 23.59 | Neutral |
| MACD(12,26) | 0.2586 | Buy |
| ADX(14) | 29.93 | Buy |
| William %R | -29.41 | Neutral |
| CCI(14) | 24.55 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.3755
Sell
|
4.277
Buy
|
| MA20 |
4.0173
Buy
|
4.0654
Buy
|
| MA50 |
3.5252
Buy
|
3.8519
Buy
|
| MA100 |
4.0949
Buy
|
3.8284
Buy
|
| MA200 |
3.7339
Buy
|
3.6549
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, ORGO could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ORGO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 59.61 indicates that ORGO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 63.06 indicates that ORGO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 23.59 indicates that ORGO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.93 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 24.55 indicates that ORGO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ORGO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Organogenesis Holdings Inc financial reports and earnings history, Organogenesis Holdings Inc (ORGO) stock could reach $1.7629 by 2030, $4.572 by 2040 and $6.8863 by 2050. See the projected annual prices until 2050 of the Organogenesis Holdings Inc stock below:
- Organogenesis Holdings Inc (ORGO) is expected to reach an average price of $1.1185 in 2035, with a high prediction of $1.5819 and a low estimate of $1.2385. This indicates an $-74.40% rise from the last recorded price of $4.37.
- Organogenesis Holdings Inc (ORGO) stock is projected to chart a bullish course in 2040, with an average price target of $4.602, representing an $5.31% surge from its current level. The forecast ranges from a conservative $4.6802 to a sky-high $4.572.
- Our analysts predict Organogenesis Holdings Inc (ORGO) to jump 59.32% by 2045, soaring from $6.91 to an average price of $6.9624, potentially reaching $6.7908. While $6.91 is the low estimate, the potential upside is significant.
- Organogenesis Holdings Inc (ORGO) stock is expected to climb by 2050, reaching an average of $6.9693, a $59.48% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.8863 and $6.7983, respectively, highlighting the market's uncertainty.
Organogenesis Holdings Inc Stock (ORGO) Year by Year Forecast
Organogenesis Holdings Inc Stock (ORGO) Price Forecast for 2025
Organogenesis Holdings Inc Stock (ORGO) is expected to reach an average price of $0.728 in 2025, with a high prediction of $1.4329 and a low estimate of $0.0231. This indicates an -83.34% fall from the last recorded price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2025 | $0.3739 | $0.1035 | $0.2065 | -91.44% |
| September, 2025 | $0.2553 | $0.0543 | $0.3858 | -94.16% |
| October, 2025 | $0.4843 | $0.0451 | $0.8349 | -88.92% |
| November, 2025 | $0.1435 | $0.03 | $0.5139 | -96.72% |
| December, 2025 | $0.00245 | $0.0231 | $1.4329 | -99.94% |
Organogenesis Holdings Inc Stock (ORGO) Price Forecast for 2026
The predicted value for Organogenesis Holdings Inc (ORGO) in 2026 is set at an average of $10.51. Estimates vary from a peak of $20.93 to a trough of $0.0878, indicating an +140.52% surge from the present price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.3816 | $0.0878 | $1.8416 | -68.38% |
| February, 2026 | $2.4608 | $0.981 | $2.7608 | -43.69% |
| March, 2026 | $5.97 | $2.2106 | $6.9799 | +36.61% |
| April, 2026 | $9.829 | $5.6798 | $11.46 | +124.92% |
| May, 2026 | $15.23 | $7.7888 | $15.44 | +248.47% |
| June, 2026 | $19.44 | $14.45 | $20.93 | +344.79% |
| July, 2026 | $15.41 | $13.51 | $20.80 | +252.55% |
| August, 2026 | $11.81 | $11.39 | $16.42 | +170.15% |
| September, 2026 | $13.20 | $11.95 | $14.12 | +202.16% |
| October, 2026 | $11.48 | $10.29 | $13.74 | +162.78% |
| November, 2026 | $13.87 | $10.04 | $14.17 | +217.46% |
| December, 2026 | $11.12 | $11.05 | $14.32 | +154.50% |
Organogenesis Holdings Inc Stock (ORGO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Organogenesis Holdings Inc (ORGO) is $6.5672, with a high forecast of $11.21 and a low forecast of $1.9227. This indicates an +50.28% increase from the last price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.511 | $6.4662 | $11.21 | +71.88% |
| February, 2027 | $6.8602 | $6.5802 | $9.2304 | +56.98% |
| March, 2027 | $6.4792 | $5.6592 | $7.6394 | +48.27% |
| April, 2027 | $5.4484 | $5.0284 | $7.389 | +24.68% |
| May, 2027 | $4.2576 | $3.738 | $5.2982 | -2.57% |
| June, 2027 | $5.7165 | $3.4669 | $6.3865 | +30.81% |
| July, 2027 | $4.7757 | $4.2059 | $6.3263 | +9.28% |
| August, 2027 | $3.9949 | $3.9649 | $5.4453 | -8.58% |
| September, 2027 | $3.2139 | $2.5243 | $4.7345 | -26.46% |
| October, 2027 | $2.4231 | $2.0181 | $3.2437 | -44.55% |
| November, 2027 | $2.4223 | $1.9227 | $2.7823 | -44.57% |
| December, 2027 | $2.0912 | $2.0012 | $3.8912 | -52.15% |
Organogenesis Holdings Inc Stock (ORGO) Price Forecast for 2028
In 2028, Organogenesis Holdings Inc (ORGO) is projected to reach an average price of $1.1732, with a high projection of $2.311 and a low estimate of $0.0353. This indicates an -73.15% fall from the last price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9004 | $0.8804 | $2.311 | -79.40% |
| February, 2028 | $0.6896 | $0.5198 | $1.18 | -84.22% |
| March, 2028 | $0.7786 | $0.519 | $0.909 | -82.18% |
| April, 2028 | $0.3178 | $0.0878 | $0.9084 | -92.73% |
| May, 2028 | $0.1767 | $0.0482 | $0.3769 | -95.96% |
| June, 2028 | $0.2359 | $0.0515 | $0.5211 | -94.60% |
| July, 2028 | $0.2651 | $0.0457 | $0.6053 | -93.93% |
| August, 2028 | $0.00591 | $0.0353 | $0.6749 | -99.86% |
| September, 2028 | $0.0667 | $0.1867 | $0.1763 | -98.47% |
| October, 2028 | $0.0875 | $0.2119 | $0.1373 | -98.00% |
| November, 2028 | $1.8014 | $0.1377 | $1.9918 | -58.78% |
| December, 2028 | $1.2006 | $1.1456 | $2.211 | -72.53% |
Organogenesis Holdings Inc Stock (ORGO) Price Forecast for 2029
The 2029 price forecast for Organogenesis Holdings Inc Stock (ORGO) is $1.4776 on average, with a high prediction of $2.8991 and a low estimate of $0.0561. This represents an -66.19% decrease from the previous price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.1996 | $0.9104 | $2.41 | -49.67% |
| February, 2029 | $0.6288 | $0.2492 | $2.3544 | -85.61% |
| March, 2029 | $0.458 | $0.438 | $0.9683 | -89.52% |
| April, 2029 | $0.4072 | $0.3078 | $1.5075 | -90.68% |
| May, 2029 | $0.2861 | $0.0561 | $0.5613 | -93.45% |
| June, 2029 | $0.8653 | $0.2209 | $0.8653 | -80.20% |
| July, 2029 | $2.2645 | $0.7751 | $2.6595 | -48.18% |
| August, 2029 | $1.5235 | $1.5135 | $2.8991 | -65.14% |
| September, 2029 | $1.7227 | $1.4231 | $2.1129 | -60.58% |
| October, 2029 | $0.9216 | $0.8023 | $1.9225 | -78.91% |
| November, 2029 | $1.2508 | $0.8712 | $1.406 | -71.38% |
| December, 2029 | $1.98 | $0.5256 | $1.4256 | -54.69% |
Organogenesis Holdings Inc Stock (ORGO) Price Forecast for 2030
Organogenesis Holdings Inc Stock (ORGO) is expected to reach an average price of $2.9444 in 2030, with a high forecast of $4.7151 and a low forecast of $1.1737. This signifies an -32.62% decrease from the last price of $4.37.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.522 | $1.9515 | $1.7629 | -65.17% |
| February, 2030 | $1.0737 | $1.1737 | $1.3429 | -75.43% |
| March, 2030 | $4.2653 | $2.7041 | $3.6053 | -2.40% |
| April, 2030 | $4.5269 | $4.4238 | $4.0961 | +3.59% |
| May, 2030 | $2.019 | $2.019 | $3.1673 | -53.80% |
| June, 2030 | $1.1206 | $1.5202 | $1.4907 | -74.36% |
| July, 2030 | $3.6727 | $1.2645 | $1.0214 | -15.96% |
| August, 2030 | $3.3543 | $3.5243 | $3.2531 | -23.24% |
| September, 2030 | $3.4359 | $3.4947 | $3.3355 | -21.37% |
| October, 2030 | $3.558 | $3.3563 | $3.3375 | -18.58% |
| November, 2030 | $3.7196 | $3.5984 | $3.8692 | -14.88% |
| December, 2030 | $5.0812 | $4.9008 | $4.7151 | +16.28% |
4.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):